- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MRI Predicts Recurrence-Free Survival in Breast Cancer
MRI can help physicians predict breast cancer recurrence in women who underwent chemotherapy and surgery.
MRI may help predict recurrence-free survival (RFS) in women with breast cancer, even in the presence of pathologic complete response (PCR) and residual cancer burden (RCB) class, according to a study published in Radiology.
Researchers from California, Rhode Island, Pennsylvania, Washington, Alabama, South Carolina, New York, Texas, Washington DC, and Illinois, performed a prospective multicenter study to evaluate volumetric MR imaging for predicting RFS after neoadjuvant chemotherapy (NACT) of breast cancer and to consider its predictive performance relative to PCR.
The study included 162 female patients with breast tumors that were 3 cm or larger. The women were scheduled to receive NACT. They underwent four examinations with dynamic contrast-enhanced MR imaging:
1. Before NACT treatment began
2. After one cycle
3. Midtherapy
4. Before surgery[[{"type":"media","view_mode":"media_crop","fid":"47312","attributes":{"alt":"MRI","class":"media-image media-image-right","id":"media_crop_8651781788049","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"5555","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 135px; width: 180px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":"©nav/Shutterstock.com","typeof":"foaf:Image"}}]]
The researchers determined functional tumor volume (FTV), computed from MR images by using enhancement thresholds, and change from baseline (ÎFTV) were measured after one cycle and before surgery.
The results showed that FTV2, FTV4, and ÎFTV4 had significant association with RFS, as did HR/HER2 status and RCB class. “PCR approached significance at univariate analysis and was not significant at multivariate analysis,” the authors wrote.
The FTV2 and RCB class had the strongest predictive performance, greater than for FTV4 and PCR. At multivariate analysis, a model with FTV2, ÎFTV2, RCB class, HR/HER2 status, age, and race had the highest C statistic (0.72; 95% CI: 0.60, 0.84).
The researchers concluded that using MR imaging to measure breast tumor FTV is a strong predictor for RFS.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
